Smith & Nephew SNATS (NYSE:SNN) Sees Large Volume Increase - What's Next?

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) saw strong trading volume on Wednesday . 1,805,283 shares traded hands during trading, an increase of 122% from the previous session's volume of 812,288 shares.The stock last traded at $30.51 and had previously closed at $29.77.

Analyst Ratings Changes

A number of equities analysts have commented on the company. Canaccord Genuity Group raised their price objective on Smith & Nephew SNATS from $27.00 to $28.00 and gave the stock a "hold" rating in a research note on Thursday, May 1st. UBS Group downgraded Smith & Nephew SNATS from a "buy" rating to a "neutral" rating in a report on Wednesday, March 12th. Hsbc Global Res downgraded Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a report on Friday, April 25th. Finally, HSBC downgraded Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a research note on Friday, April 25th. Six investment analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $28.00.

Smith & Nephew SNATS Trading Up 1.2%

The business has a 50 day moving average of $29.24 and a two-hundred day moving average of $27.37. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.89. The firm has a market capitalization of $13.60 billion, a price-to-earnings ratio of 14.37, a P/E/G ratio of 0.94 and a beta of 0.69.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. J. Goldman & Co LP bought a new stake in Smith & Nephew SNATS during the 4th quarter worth approximately $47,700,000. Goldman Sachs Group Inc. increased its holdings in Smith & Nephew SNATS by 49.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider's stock worth $50,255,000 after purchasing an additional 583,809 shares in the last quarter. Armistice Capital LLC increased its holdings in Smith & Nephew SNATS by 258.1% during the 1st quarter. Armistice Capital LLC now owns 1,769,000 shares of the medical equipment provider's stock worth $50,187,000 after purchasing an additional 1,275,000 shares in the last quarter. Brandes Investment Partners LP increased its holdings in Smith & Nephew SNATS by 11.4% during the 4th quarter. Brandes Investment Partners LP now owns 1,363,039 shares of the medical equipment provider's stock worth $33,504,000 after purchasing an additional 138,994 shares in the last quarter. Finally, Clark Estates Inc. NY increased its holdings in Smith & Nephew SNATS by 6.3% during the 1st quarter. Clark Estates Inc. NY now owns 850,000 shares of the medical equipment provider's stock worth $24,114,000 after purchasing an additional 50,000 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.

About Smith & Nephew SNATS

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.